Fact CheckerSign in

NCT05425277Completed

Assessing the Effectiveness of Reciprocal Imitation Teaching in Part C Early Intervention Settings (Sprout Study)

Assessing the Effectiveness of a Low-Cost, Evidence-Based Naturalistic Developmental Behavioral Intervention (NDBI) in IDEA Part C Early Intervention Settings

Source: ClinicalTrials.gov · Last updated 22 Nov 2024

Brief summary (registry, in English)

Despite strong consensus that early, specialized intervention for children with Autism Spectrum Disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. The goal of this research project is to improve services and outcomes for children with early signs of ASD by testing the effectiveness of a brief, inexpensive training on EI providers' ability to deliver an evidence-based, caregiver-mediated intervention that can improve providers' comfort and effectiveness in working with families of children with social communication concerns, as well as improving child and family outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
91 (actual)
First submitted
12 Jun 2022
Start date
15 May 2021
Primary completion date
5 Jan 2024
Lead sponsor
University of Washington
Diseases
Autism
NCT number
NCT05425277

What you commit to

  • Study type: Interventional
  • Participants enrolled: 91
  • From 15 May 2021 to the primary completion date, 5 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Child has no severe visual, auditory, or physical impairments and no serious medical, genetic, or neurological conditions that would impede their ability to engage in RIT.

Who the study is looking for

  • EI Providers:
  • Speak and read English
  • Work at a participating Part C practice or agency
  • Have an active caseload that includes at least two children with ASD or suspected ASD
  • Are willing to invite families to participate in this study
    • Caregivers and Toddlers (recruited from EI provider caseloads):
  • Caregivers speak and read English or Spanish
  • Caregivers are at least 18 years of age
  • Caregivers are willing and able to participate in intervention sessions and research tele-visits that are video-recorded by research staff
  • Child receives services from one of the participating agencies and attends regular sessions with the enrolled provider
  • Child is between 18 and 30 months of age at study entry
  • Child has a diagnosis of ASD or displays social communication impairments consistent with ASD

Age in the registry: 18 months to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Washington
Coordinator of this site? Confirm its status
SeattleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.